PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayA rare digenic combination of heterozygous mutations in the LRRK2 and MAPT genes is associated with dopaminergic degeneration, interferon-mediated neuroinflammation, and gut–brain axis disruption in Parkinson’s disease, according to research published in the Journal of Neuroinflammation. These dual-variant cases present with complex clinical manifestations, and the underlying molecular mechanisms driving their pathology have historically remained unclear.
The investigation centered on a familial Parkinson’s disease patient identified as carrying heterozygous LRRK2 P1446L and MAPT R5H variants. Detailed clinical evaluation of the proband revealed an early-onset and rapidly progressive course of Parkinson’s disease.
To investigate the molecular and phenotypic consequences of these mutations, the researchers deployed three experimental models: patient-derived induced pluripotent stem cells, knock-in mouse models, and dopaminergic cell lines. Using these complementary experimental systems, the team conducted transcriptomic profiling alongside 16S microbiome analyses to uncover the specific pathogenic pathways involved.
In cellular experiments, dopaminergic neurons differentiated from the patient’s induced pluripotent stem cells exhibited distinct pathological alterations.
The researchers next examined phenotypic outcomes in vivo by studying knock-in mouse models harboring the dual genetic mutations. Compared directly to control mice carrying only a single genetic mutation, animals with the LRRK2 P1446L and MAPT R5H digenic mutant combination displayed aggravated motor deficits. Pathological evaluations further established that the digenic combination caused aggravated dopaminergic neuron loss and increased alpha-synuclein aggregation in brain tissues when compared to control mice carrying single mutations.
To determine the molecular mechanisms underlying the neurodegenerative and neuroinflammatory phenotype, the researchers conducted transcriptomic profiling of midbrain tissues. This profiling revealed strong activation of type I interferon signalling mediated by the STING–TBK1–IRF3 pathway.
In addition to neurological assessments, 16S microbiome analyses revealed pronounced gut dysbiosis in the digenic mutant mice compared to controls. This gut microbiota dysregulation was characterized by an increased relative abundance of Alloprevotella and Lactobacillaceae, alongside a decreased abundance of Akkermansiaceae. Together, these results demonstrate that the LRRK2 P1446L and MAPT R5H variant combination is associated with dopaminergic degeneration, interferon-mediated neuroinflammation, and gut–brain axis disruption in Parkinson’s disease.
Subject of Research: Digenic LRRK2 and MAPT mutations in Parkinson's disease neuroinflammation and gut dysbiosis
Article Title: LRRK2P1446L/MAPTR5H rare variants drive interferon-mediated neuroinflammation and gut microbiota dysregulation in Parkinson’s disease
Article References: Lu, L., Ding, L., Xu, Z., Tang, L., Zhu, Z., Chen, M., Shu, H., Luo, K., Chen, Z., Han, T., Huang, X., Yang, X., Zhang, W., & Xu, P. (2026). LRRK2P1446L/MAPTR5H rare variants drive interferon-mediated neuroinflammation and gut microbiota dysregulation in Parkinson’s disease. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-026-04059-9
Image Credits: AI Generated
DOI: 10.1186/s12974-026-04059-9
Keywords: Parkinson's disease, LRRK2 P1446L, MAPT R5H, digenic mutations, neuroinflammation, type I interferon, STING-TBK1-IRF3 pathway, gut microbiota, dysbiosis, dopaminergic neurons, tyrosine hydroxylase, alpha-synuclein, induced pluripotent stem cells, knock-in mouse models, Alloprevotella, Lactobacillaceae, Akkermansiaceae, gut-brain axis


1 day ago
13




















English (US) ·
French (CA) ·